Find technical documentation on our products as well as scientific references. Learn about the ways our customers are using our products in research applications and peptide development.
The speed and flexibility of peptide synthesis is a major advantage over protein-based biologics when handling rapidly evolving conditions, such as therapeutics related to SARS-CoV-2 vaccine development and neoantigen peptide-based vaccines. Download the white paper to learn more on how to optimize the synthesis of multiple peptides with therapeutic potential, with a real-world example of optimizing SARS-CoV-2 peptides for epitope analysis.
While many therapeutic peptides are variants of natural peptides, advances in #SolidPhasePeptideSynthesis has enabled the design of more refined molecules that are more readily able to penetrate the cell membrane, more stable, and resistant to degradation. The demand for increasingly complex therapeutic peptides has resulted in the development of robust, efficient, and rapid synthesis protocols and instrumentation that can meet the demands of GxP and regulatory authorities. Download the white paper to read more about synthesizing complex therapeutic peptides.